In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man

Author： Ericsson H.   Tholander B.   Regardh C.G.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.8, Iss.1, 1999-04, pp. : 29-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine

By Segawa D.   Sjoquist P.-O.   Nordlander M.   Wang Q.-D.   Gonon A.   Ryden L.  

European Journal of Pharmacology, Vol. 380, Iss. 2, 1999-09 ,pp. : 123-128

Elsevier

Access to resources Recommend Favorite

Clevidipine

By  

Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. : 190-192

Adis International

Access to resources Recommend Favorite

The Use of Ultra-Short-Acting Opioids in Paediatric Anaesthesia: The Role of Remifentanil

By Davis Peter J.   Cladis Franklyn P.  

Clinical Pharmacokinetics, Vol. 44, Iss. 8, 2005-01 ,pp. : 787-796

Adis International

Access to resources Recommend Favorite

Azelnidipine, a New Long-acting Calcium-channel Blocker, Inhibits Tumour Necrosis Factor-α-induced Monocyte Chemoattractant Protein-1 Expression in Endothelial Cells

By Matsui T   Yamagishi S   Nakamura K   Inoue H  

The Journal of International Medical Research, Vol. 34, Iss. 6, 2006-11 ,pp. : 671-675

Field House Publishing

Access to resources Recommend Favorite

Insurmountable AT 1 receptor antagonism: the need for different antagonist binding states of the receptor

By Vauquelin G.   Fierens F.   Verheijen I.   Vanderheyden P.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. : 343-344

Elsevier

Access to resources Recommend Favorite